Certified according to
DIN EN ISO 13485:2016
RBC-FluoGene® Q
RBC-FluoGene® Q
The flexible blood group diagnostics for every Real-time cycler
The new FluoGene® Q series consists of liQuid mixes and is detached from the inno-train instruments and the FluoGene® software. The qPCR kits consist of a few, usually 1-2, primer-probe mixes, the FluoMix, and one positive and one negative control DNA. The reagents can be used on any Real-time instrument in both 96 and 384 blocks.
Advantages of the RBC-FluoGene® Q
qPCR in liquid format for flexible screening.
Control DNA included in the kit.
Only one pipetting step.
Less than 5 minutes hands-on time.
80 minutes from DNA to result.
Suitable for any Real-time PCR instrument.
25 years of experience in RBC genotyping.
RBC-FluoGene® RHD Zygosity Q
For RHD zygosity determination, a distinction must be made between DD (RHD*01/*01) and Dd (RHD*01/*01N.01) samples. The RBC-FluoGene® RHD Zygosity Q test system is a fluorescence-based quantification of RHD exons 1 and 10 from genomic DNA for the determination of RHD zygosity by Real-time PCR. The calculation of RHD zygosity is done via ΔΔCt-value.
RBC-FluoGene® D weak Screen Q
The D weak Screen Q test identifies the alleles RHD*01W.1, RHD*01W.2, and RHD*01W.3 classified as D positive in one reaction. With the 2nd mix, in combination with the first mix, a separation of the RHD*09 allele cluster occurs, separating the D weak type 4.0/4.1 alleles from 4.2 and 4.3.
On a 96-well plate, a screening of 96 samples for D+ alleles are possible (Mix 1 only), or 48 samples with additional separation of the RHD*09 alleles. The evaluation is performed using the Ct value calculation of the used Real-time instrument.
Downloads
Flyer RBC-FluoGene® RHD Zygosity Q
Flyer FluoGene® D weak Screen Q
Products:
RBC-FluoGene Q
| Item number | Name |
|---|---|
| 001 094 024Q | RBC-FluoGene RHD Zygosity Q |
| 001 093 100Q | RBC-FluoGene D weak Screen Q |
